OHSU Knight Cancer Institute Research Groups:OCI Cancer Journal Club: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(48 intermediate revisions by 9 users not shown)
Line 10: Line 10:
Want to join us? All are invited!
Want to join us? All are invited!
*To get on the listserve:  
*To get on the listserve:  
:Begin a new e-mail and address it to: majordomo@ohsu.edu (must be sent as a plain text email)
:go to the following web site:
:Type 'subscribe oncobio' into the subject line AND
:http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncobio
:Type 'subscribe oncobio' into the text box of the e-mail and send
:follow instructions for subscribing
*To send out your paper  
*To send out your paper  
:Send an e-mail to 'oncobio' with your paper attached
:Send an e-mail to 'oncobioATohsu.edu' with your paper attached
*When and where we meet
*When and where we meet
:MacHall 2136
:MacHall 2136
Line 50: Line 50:


|--
|--
|9/29/2011
|9/27/2012
|Charlie Lopez
|Rosalie Sears
|Organization
|Organization
|
|
|--
|--
|10/6/2011
|10/4/2012
|xxxxxxxxxx
|Brittany Allen-Petersen
|CANCEL
|Tumourmicro-environment elicits innate resistance to RAF inhibitors through HGF secretion
|xxxxxxxxxx
|[http://www.nature.com/nature/journal/v487/n7408/full/nature11183.html Straussman et al]
|--
|--
|10/13/2011
|10/11/2012
|Xiaoli Zhang
|Ellen Langer
|Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms
|A restricted cell population propagates glioblastoma growth after chemotherapy
|[http://openwetware.org/images/8/87/PI3KCA_and_Myc.2402.pdf PI3KCA mechanisms]
|[http://openwetware.org/images/3/3a/Chen_Nature_2012.pdf Chen, et al] Additional vivo detection papers [http://www.ncbi.nlm.nih.gov/pubmed/22854777 1] [http://www.ncbi.nlm.nih.gov/pubmed/22855427 2]
|--
|--
|10/20/2011
|10/18/2012
|Rosie Sears
|Yulong Su
|Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
|Transcriptional Amplification in Tumor Cells with Elevated c-Myc;
|[http://openwetware.org/wiki/Image:Goetz.pdf Goetz 2009]  
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
|[http://www.sciencedirect.com/science/article/pii/S0092867412010574 Lin 2012]
[http://www.sciencedirect.com/science/article/pii/S0092867412011014 Nie 2012]
|--
|--
|10/27/2011
|10/25/2012
|Katy Van Hook
|****CANCELLED****  Dr. Charles Lopez
| Competative RNA
| Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
|[http://openwetware.org/wiki/Image:Karreth_2011.pdf Karreth (2011)]
|[http://openwetware.org/images/a/a5/Nature11156.pdf Misale at. al] [http://openwetware.org/images/3/33/Nature11156-s1.pdf supp. info]
|--  
|--  
|11/3/2011
|11/1/2012
|Mushui Dai
|Asia Mitchell
|A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability. Mol Cell. 2011 Sep 16;43(6):1023-32.
|Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
|http://www.sciencedirect.com/science/article/pii/S109727651100640X
|[http://www.sciencedirect.com/science/article/pii/S0092867412004199]
|--
|--
|11/10/2011
|11/8/2012
|Charlie Lopez
|Yuhan Wang
|CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
|"Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Melanoma"
|[http://openwetware.org/images/c/c5/Science-2011-Beatty-1612-6%281%29.pdf science 2011 Beatty]
|[http://openwetware.org/images/4/4e/Journal_Club_paper-5hmc.pdf]
|--
|--
|11/17/2011
|11/15/2012
|canceled
|Tyler Risom
|  
|Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer
|
| [http://openwetware.org/images/8/85/PI3K_and_Parp_1.full.pdf Ashish et. al.] [http://openwetware.org/images/8/82/PI3K_and_Parp_2.full.pdf Yasir et al]
|--
|--
|11/24/2011
|11/22/2012
|xxxxxxxxxx
|xxxxxxxxxx
|THANKSGIVING, NO JOURNAL CLUB
|THANKSGIVING, NO JOURNAL CLUB
|xxxxxxxxxx
|xxxxxxxxxx
|--
|--
|12/1/2011
|11/29/2012
|Aaron Wortham
|Dr. Swarnali Acharyya, a CDB/Knight faculty candidate seminar
|The Eph-Receptor A7 is a Soluble Tumor Suppressor for Follicular Lymphoma
|
|[http://openwetware.org/wiki/Image:EPHA7_and_FL.pdf Oricchio E et al 2011 Cell]
|
|--
|--
|12/8/2011
|12/6/2012
|Myron Peto
|Marilynn Chow
|   
|   
|
|
|--
|--
|12/15/2011
|1/10/2013
|Chuck Pham Jr
|Lilli Welch
|Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
|http://www.mendeley.com/research/efficient-delivery-liposomemediated-mgmtsirna-reinforces-cytotoxity-temozolomide-gbminitiating-cells/
|--
|1/5/2012
|Tim Butler
|
|
|
|
|--
|--
|1/12/2012
|1/17/2013
|Jared Fischer
|Spencer Watson
|
|
|
|
|--
|--
|1/19/2012
|1/24/2013
|Yulong Su
|Ping Wang
|
|
|
|
|--
|--
|1/26/2012
|1/31/2013
|Yuangang Liu
|Jared Fischer
|
|
|
|
|--
|--
|2/2/2012
|2/7/2013
|Mahnaz Janghorban
|Mahnaz Janghorban
|
|
|
|
|--
|--
|2/9/2012
|2/14/2013
|Tiffany DeVine
|Tiffany Devine
|
|
|
|
|--
|--
|2/16/2012
|2/21/2013
|Jason Link
|Ellie Juarez
|
|
|
|
|--
|--
|2/23/2012
|2/28/2013
|Ellen Langer
|Toni West
|
|
|
|
|--
|--
|3/1/2012
|3/7/2013
|Aaron Jacobs
|Tim Butler
|
|
|
|
|--
|--
|3/8/2012
|3/14/2013
|Vince Bicocca
|Aaron Wortham
|
|
|
|
|--
|--
|3/15/2012
|3/21/2013
|John Oyer
|
|
|
|
|
|--
|--
|3/22/2012
|4/4/2013
|Arthur Edwards
|Nathalie Javidi-Sharifi
|
|
|
|
|--
|--
|4/5/2012
|4/11/2013
|Kinrin Yamanaka
|Kevin Watanabe-Smith
|
|
|
|
|--
|--
|4/12/2012
|4/18/2013
|Stacey Lin
|
|
|
|
|
|--
|--
|4/19/2012
|4/25/2013
|Juan Liang
|
|
|
|
|
|--
|--
|4/26/2012
|5/2/2013
|Jeff Wu
|Stacey Lin
|
|
|
|
|--
|--
|5/3/2012
|5/9/2013
|Amy Farrell
|Juan Liang
|
|
|
|
|--
|--
|5/10/2012
|5/16/201
|Xiaoxin Sun
|Xiaoxin Sun
|
|
|
|
|--
|--
|5/17/2012
|5/23/2013
|Nathalie Javidi-Sharifi
|Dr. Charles Lopez
|
|
|
|
|--
|--
|5/24/2012
|5/30/2013
|Nichole Owen
|
|
|
|
|
|--
|--
|5/31/2012
|6/6/2013
|Zhiping Wang
|
|
|
|--
|6/7/2012
|Kishore Challagundla
|
|
|
|
|}
|}
</div>
</div>

Revision as of 18:22, 13 November 2012

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Objectives of the OHSU Cancer Biology Journal Club

Cross-departmental journal club composed of students, postdocs, fellows and clinical and basic science faculty with shared interest in basic principles, emerging discoveries, and new therapeutic approaches in Cancer Biology. The goals of the meetings are to:

  • Critically evaluate new cutting edge literature on mechanisms underlying the development and maintenance of cancer to inform the development of new therapeutics. Papers should be paradigm shifting and set a backdrop for discussion into therapeutics facilitated by the clinical attendees.
  • Provide students, postdocs and fellows with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

KCI CJC Information

Want to join us? All are invited!

  • To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncobio
follow instructions for subscribing
  • To send out your paper
Send an e-mail to 'oncobioATohsu.edu' with your paper attached
  • When and where we meet
MacHall 2136
Thursdays noon-1 PM
Lunch provided by KCI
  • Organizer contact information:
Rosie Sears-searsr@ohsu.edu
Charlie Lopez- lopezc@ohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab

Hoatlin Lab

Thayer Lab

Wong Lab

Lloyd Lab CROET

McCullough Lab CROET

Schedule

  • Scheduling In Progress
Date Presenters Topic Links & Comments
9/27/2012 Rosalie Sears Organization
10/4/2012 Brittany Allen-Petersen Tumourmicro-environment elicits innate resistance to RAF inhibitors through HGF secretion Straussman et al
10/11/2012 Ellen Langer A restricted cell population propagates glioblastoma growth after chemotherapy Chen, et al Additional vivo detection papers 1 2
10/18/2012 Yulong Su Transcriptional Amplification in Tumor Cells with Elevated c-Myc;

c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells

Lin 2012

Nie 2012

10/25/2012 ****CANCELLED**** Dr. Charles Lopez Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer Misale at. al supp. info
11/1/2012 Asia Mitchell Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks [1]
11/8/2012 Yuhan Wang "Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Melanoma" [2]
11/15/2012 Tyler Risom Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer Ashish et. al. Yasir et al
11/22/2012 xxxxxxxxxx THANKSGIVING, NO JOURNAL CLUB xxxxxxxxxx
11/29/2012 Dr. Swarnali Acharyya, a CDB/Knight faculty candidate seminar
12/6/2012 Marilynn Chow
1/10/2013 Lilli Welch
1/17/2013 Spencer Watson
1/24/2013 Ping Wang
1/31/2013 Jared Fischer
2/7/2013 Mahnaz Janghorban
2/14/2013 Tiffany Devine
2/21/2013 Ellie Juarez
2/28/2013 Toni West
3/7/2013 Tim Butler
3/14/2013 Aaron Wortham
3/21/2013
4/4/2013 Nathalie Javidi-Sharifi
4/11/2013 Kevin Watanabe-Smith
4/18/2013
4/25/2013
5/2/2013 Stacey Lin
5/9/2013 Juan Liang
5/16/201 Xiaoxin Sun
5/23/2013 Dr. Charles Lopez
5/30/2013
6/6/2013
Retrieved from "https://openwetware.org/mediawiki/index.php?title=OHSU_Knight_Cancer_Institute_Research_Groups:OCI_Cancer_Journal_Club&oldid=653845"